I've spent this rainy Sydney Sunday researching my next BioTech buy - and I'm struggling to find a reason why not to buy into AHZ.
In particular, the CardioCel FDA approval, allowing marketing and sale in the US looks huge.
I've just sent the info across to a mate of mine who is a cardiac surgeon, I've asked if he can allow me to post his reply to the information on the Admedus site.
I'll read through the rest of the posts from the past few weeks / months on here, but so far it's looking impressive. Bit of a gamble with the hpv stuff.
My main question is this; is anyone else doing something similar to the CardioCel, or is it proprietary for AHZ?
why wouldn't i buy?
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.30 |
Change
-0.400(1.84%) |
Mkt cap ! $409.1M | |||
| Open | High | Low | Value | Volume |
| $21.46 | $21.50 | $21.15 | $56.44K | 2.653K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 51 | $21.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.42 | 10 | 1 |
View Market Depth
| Last trade - 16.10pm 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$21.31 |
Change
-0.400 ( 0.37 %) |
||||
| Open | High | Low | Volume | ||
| $21.49 | $21.50 | $21.29 | 203 | ||
| Last updated 15.59pm 02/05/2024 ? | |||||
| AVR (ASX) Chart |